Aleksandra Babic
Bellinzona, TI, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Nutritional support in stem cell transplantation programs: Results from a multicenter survey of nurses on behalf of the Nurses Group and Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation and the Gruppo Italiano Trapianto di Midollo Osseo.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: April 21, 2020
Health-care professionals' perspective on discussing sexual issues in adult patients after haematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: January 31, 2017
Management of veno-occlusive disease: the multidisciplinary approach to care.
Journal: European journal of haematology
Published: December 07, 2016
R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: December 05, 2013
Efficacy of photopheresis extracorporeal procedure as single treatment for severe chronic GVHD: a case report.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: June 27, 2012
Successful mobilisation of peripheral blood stem cells in children using plerixafor: a case report and review of the literature.
Journal: Blood transfusion = Trasfusione del sangue
Published: March 19, 2012
Who should be really considered as a poor mobilizer in the plerixafor era?
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: October 21, 2011
Plerixafor and Filgrastim XM02 (Tevagastrim) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation.
Journal: European journal of haematology
Published: October 14, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026